BOC Sciences, one of the front-runners in chemical material manufacturing and custom services for the full drug product lifecycle, today reported strong growth over the past year in its expanded contract development and manufacturing (CDMO) platform.

BOC Sciences unveils its comprehensive capabilities of custom peptide drug conjugate from project design to commercial production.

The chief technician of BOC Sciences ADC development center recently reported some detailed information regarding its antibody modification and conjugation technologies.

BOC Sciences recently launched the PEG GMP manufacture service, a novel solution that aims at providing GMP-grade PEG products for a wide scope of applications.

"No matter what region of the world you are in, you can trust BOC Sciences in the custom ingredient manufacturing skills that have been fully vetted for quality, safety, compliance, and reliability," the BOC Sciences technical director said.

Towards the end of 2022, BOC Sciences introduced its metabolite manufacturing abilities, particularly the production of Aureobasidin A for gene research and drug development.

It's verified by BOC Sciences officials that the critical specialty chemical distearyl phthalic acid amide is now in steady supply, aiming to accelerate the development of cosmetics industry.

BOC Sciences provides global customers with a range of high-quality stable isotope labeling compounds for biomedical research. It recently announced the availability of labeled carbohydrates, arousing an enthusiastic response from the market.

BOC Sciences declares that some of its peptide products have been proven applicable for osteoporosis treatment, which is a significant contribution to the therapeutic areas.

Owing to the continuously upgraded synthesis technologies and analytical abilities, BOC Sciences has performed well in the polymer industry, serving the community with a comprehensive product portfolio and valuable technical support.

BOC Sciences announces support for antibody-drug conjugate (ADC) development, registration, and release by providing comprehensive analysis and characterization technologies.

BOC Sciences is able to provide clients with high-standard fermented raw materials that satisfy the quality attributes of finished healthcare products.

The chief technician of BOC Sciences ADC development center recently reported some detailed information regarding its antibody modification and conjugation technologies.

BOC Sciences' chemical products have been applied in a wide range of research projects and helped achieve groundbreaking breakthroughs.

BOC Sciences recently confirmed to its customers that over 10,000 impurities are now in stock, ready for immediate delivery.

As the leading expert in computer-aided drug discovery, BOC Sciences has developed compound docking technologies to facilitate the discovery of novel ligands for over 30 targets.

BOC Sciences grandly announced the schedule of a free webinar on September 19th, 2022, at 11:00 EDT, which is a laudable event centering on the hot spot of RNA research during the pandemic.

BOC Sciences provides pseudoUridine phosphoramidites for efficient and reliable syntheses of RNA oligonucleotides containing single or multiple pseudoUridine modifications.

BOC Sciences developed strain expression systems for fermentation to help researchers greatly enhance fermentation productivity while significantly reducing costs.

BOC Sciences offers high-quality peptide-siRNA conjugates to help clients achieve substantial preclinical progress for RNAi therapeutics.

BOC Sciences has been constantly enriching its peptide product library for years. Its peptides for diabetes research are recently brought into focus due to the growing concerns on this problem.

Whether they are small quantities of APIs for initial development work or many kilograms for a late phase trial, BOC Sciences whose reputation is built on excellence in chemistry can raise the bar on quality.

Whether they are small quantities of APIs for initial development work or many kilograms for a late phase trial, BOC Sciences whose reputation is built on excellence in chemistry can raise the bar on quality.

BOC Sciences offers flexible ADC enzymatically cleavable linkers at competitive prices and quality.

BOC Sciences updates various stable isotope-labeled compounds at competitive prices for clients to power up COVID-related research and other scientific studies.

BOC Sciences demonstrates its comprehensive strength with innovative LYTAC degradation technology solutions developed in the field of targeted protein degradation.

BOC Sciences released a complete set of ADC drug development services for various targets to help pharmaceutical partners drive forward innovative cancer treatment research.

BOC Sciences' comprehensive fermentation CDMO services and small microbial molecules have delivered tremendous value to the pharmaceutical industry. And the future looks even better.

Cosmetic peptide synthesis and production is now attached much attention by BOC Sciences officials to meet the increasing demand for cosmetic applications.

BOC Sciences exhibited a whole set of preclinical CRO & fermentation CDMO services and attracted many interested visitors stopping by to have an informative in-person meeting.

There are several new varieties of oligo synthesis services launched by BOC Sciences in the past few months, greatly enriching its synthesis service package.

BOC Sciences recently stands out in the competitive market with optimal pseudoUridines and derivatives serving world-renowned vaccine manufacturers.

BOC Sciences successfully participated in TIDES USA 2022 from May 9th to 12th, at Hynes Convention Center, Boston.

As the grand hybrid event TIDES USA 2022 is drawing to a close, BOC Sciences is reviewing its gains there, particularly many instructive thoughts and comments collected from global researchers.

BOC Sciences recently initiated an unprecedentedly comprehensive CDMO service platform to accelerate technology transfer of medicines from research to commercial scale.

As the two industry-renowned exhibitions—CPhI North America and TIDES USA 2022 draw near, BOC Sciences is making final efforts to let the news reach as many researchers as possible.

BOC Sciences has prepared a long list of first-rate pseudoUridines to be presented at two industry-renowned exhibitions—CPhI North America and TIDES USA 2022.

BOC Sciences has prepared a long list of first-rate pseudoUridines to be presented at two industry-renowned exhibitions—CPhI North America and TIDES USA 2022.

BOC Sciences announces the provision of pharmaceutical impurities to assist in drug development.

BOC Sciences recently introduces pharmaceutical impurity identification services to accelerate drug development.

BOC Sciences announces to promote four APIs, namely Daunorubicin, Doxorubicin, Epirubicin and Valrubicin for cancer treatment.